
Despite Early Warnings Of An Omicron Surge, Testing Remains A Problem Nationwide
The NPR Politics Podcast
00:00
Advancements in COVID-19 Treatment: The Promise of Antiviral Pills
This chapter explores the new antiviral pill Paxlovid, authorized by the FDA for high-risk COVID-19 patients, noting its efficacy in reducing hospitalization and mortality. It also discusses the availability challenges and compares Paxlovid with existing treatments, highlighting the limitations of monoclonal antibodies against the Omicron variant.
Play episode from 10:12
Transcript


